98 related articles for article (PubMed ID: 3857121)
21. Sarcoma growth factor and other transforming peptides produced by human cells: interactions with membrane receptors.
Todaro GJ; De Larco JE; Fryling CM
Fed Proc; 1982 Nov; 41(13):2996-3003. PubMed ID: 6292003
[TBL] [Abstract][Full Text] [Related]
22. Characterization and partial purification of human epithelial transforming growth factor.
Dunnington DJ; Scott RG; Anzano MA; Greig R
J Cell Biochem; 1990 Dec; 44(4):229-39. PubMed ID: 2095367
[TBL] [Abstract][Full Text] [Related]
23. Comparison of growth factors functionally related to epidermal growth factor in the urine of normal and human tumor-bearing athymic mice.
Twardzik DR; Kimball ES; Sherwin SA; Ranchalis JE; Todaro GJ
Cancer Res; 1985 May; 45(5):1934-9. PubMed ID: 3872712
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factors in the urine of normal, pregnant, and tumor-bearing humans.
Twardzik DR; Sherwin SA; Ranchalis J; Todaro GJ
J Natl Cancer Inst; 1982 Oct; 69(4):793-8. PubMed ID: 6288992
[TBL] [Abstract][Full Text] [Related]
25. Isolation and partial purification of a new class of transforming growth factors from an avian sarcoma virus-transformed rat cell line.
Hirai R; Yamaoka K; Mitsui H
Cancer Res; 1983 Dec; 43(12 Pt 1):5742-6. PubMed ID: 6315215
[TBL] [Abstract][Full Text] [Related]
26. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
Tucker RF; Volkenant ME; Branum EL; Moses HL
Cancer Res; 1983 Apr; 43(4):1581-6. PubMed ID: 6299525
[TBL] [Abstract][Full Text] [Related]
27. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
[TBL] [Abstract][Full Text] [Related]
28. Analysis of human ascites effect on clonogenic growth of human tumor cell lines and NRK-49F cells in soft agar.
Broxterman HJ; Sprenkels-Schotte C; Engelen P; Leyva A; Pinedo HM
Int J Cell Cloning; 1987 Mar; 5(2):158-69. PubMed ID: 3572052
[TBL] [Abstract][Full Text] [Related]
29. Characterization of autostimulatory and transforming growth factors from human melanoma cells.
Richmond A; Lawson DH; Nixon DW; Chawla RK
Cancer Res; 1985 Dec; 45(12 Pt 1):6390-4. PubMed ID: 3864531
[TBL] [Abstract][Full Text] [Related]
30. Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression.
Rak JW; Hegmann EJ; Lu C; Kerbel RS
J Cell Physiol; 1994 May; 159(2):245-55. PubMed ID: 8163565
[TBL] [Abstract][Full Text] [Related]
31. Purification of melanoma growth stimulatory activity.
Richmond A; Thomas HG
J Cell Physiol; 1986 Dec; 129(3):375-84. PubMed ID: 3465735
[TBL] [Abstract][Full Text] [Related]
32. Antagonistic actions of retinoic acid and dexamethasone on anchorage-independent growth and epidermal growth factor binding of normal rat kidney cells.
Roberts AB; Anzano MA; Lamb LC; Smith JM; Sporn MB
Cancer Res; 1984 Apr; 44(4):1635-41. PubMed ID: 6322983
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factors in solid human malignant neoplasms.
Nickell KA; Halper J; Moses HL
Cancer Res; 1983 May; 43(5):1966-71. PubMed ID: 6299535
[TBL] [Abstract][Full Text] [Related]
34. Modulation of human tumor colony growth in soft agar by serum.
Hamburger AW; White CP; Dunn FE; Citron ML; Hummel S
Int J Cell Cloning; 1983 Sep; 1(4):216-29. PubMed ID: 6366083
[TBL] [Abstract][Full Text] [Related]
35. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia.
Rønnov-Jessen L; Petersen OW
Lab Invest; 1993 Jun; 68(6):696-707. PubMed ID: 8515656
[TBL] [Abstract][Full Text] [Related]
36. High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer.
Sherwin SA; Twardzik DR; Bohn WH; Cockley KD; Todaro GJ
Cancer Res; 1983 Jan; 43(1):403-7. PubMed ID: 6600160
[TBL] [Abstract][Full Text] [Related]
37. The purification of an acid- and heat-labile transforming growth factor from an avian sarcoma virus-transformed rat cell line.
Yamaoka K; Hirai R; Tsugita A; Mitsui H
J Cell Physiol; 1984 Jun; 119(3):307-14. PubMed ID: 6327732
[TBL] [Abstract][Full Text] [Related]
38. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells.
Anzano MA; Roberts AB; Meyers CA; Komoriya A; Lamb LC; Smith JM; Sporn MB
Cancer Res; 1982 Nov; 42(11):4776-8. PubMed ID: 6290046
[TBL] [Abstract][Full Text] [Related]
39. Autocrine tumor cell growth-inhibiting activities from human malignant melanoma.
Bogdahn U; Apfel R; Hahn M; Gerlach M; Behl C; Hoppe J; Martin R
Cancer Res; 1989 Oct; 49(19):5358-63. PubMed ID: 2766302
[TBL] [Abstract][Full Text] [Related]
40. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line.
Hasina R; Matsumoto K; Matsumoto-Taniura N; Kato I; Sakuda M; Nakamura T
Br J Cancer; 1999 Aug; 80(11):1708-17. PubMed ID: 10468286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
